Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Comparing Infusion-Related Reactions of the First Full Dose (600 Mg) Biosimilar Ocrelizumab Administration With the Standard Divided Protocol in Multiple Sclerosis Patients: A Randomized Controlled Trial Study
Mohsen Nikbakht
Mohsen Nikbakht

Associate Professor of Medical Biotechnology

Shariati Hospital

Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center

Tehran University of Medical Sciences

All Documents
17. The Question of Survival or Death: What Is the Role of Autophagy in Acute Myeloid Leukemia (Aml)?, International Journal of Hematology-Oncology and Stem Cell Research (2022)
24. A Single Center Study of Prescribing and Treatment Outcomes of Patients With Chronic Myeloid Leukemia, International Journal of Hematology-Oncology and Stem Cell Research (2020)
26. Effects of Mobilized Peripheral Blood Stem Cells on Treatment of Primary Lower Extremity Lymphedema, Journal of Vascular Surgery: Venous and Lymphatic Disorders (2020)
32. Sorafenib and Mesenchymal Stem Cell Therapy: A Promising Approach for Treatment of Hcc, Evidence-based Complementary and Alternative Medicine (2020)
48. Anti-Apoptotic Effects of Osteopontin Via the Up-Regulation of Akt/Mtor/Β-Catenin Loop in Acute Myeloid Leukemia Cells, International Journal of Hematology-Oncology and Stem Cell Research (2017)